Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thorax Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT02252796
What this trial is testing

Phase I Hypofractionated Stereotactic Boost (Radiotherapy) for Non-Small Cell Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
West Virginia University 1
Very early researchLooking for participantsNCT06097962
What this trial is testing

Safety and Efficacy of NK510 to Treat NSCLC

Who this might be right for
NSCLC
Base Therapeutics (Shanghai) Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT03520842
What this trial is testing

Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell Lung Cancer

Who this might be right for
KRAS Gene MutationMetastatic Malignant Neoplasm in the BrainRecurrent Non-Small Cell Lung Carcinoma+1 more
Stanford University 22
Early research (Phase 1)Study completedNCT00729742
What this trial is testing

Phase I Imaging Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (MK-0646-008)

Who this might be right for
Carcinoma, Non-small Cell Lung
Merck Sharp & Dohme LLC 49
Testing effectiveness (Phase 2)Study completedNCT00066742
What this trial is testing

Tirapazamine Combined With Chemo and RT in Limited-Stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
National Cancer Institute (NCI) 72
Post-approval studies (Phase 4)Looking for participantsNCT05663242
What this trial is testing

The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action

Who this might be right for
Lung CancerProgression, DiseaseAnesthesia
Kaohsiung Medical University Chung-Ho Memorial Hospital 300
Not applicableLooking for participantsNCT04706754
What this trial is testing

Pan-Canadian Lung Cancer Observational Study (PALEOS)

Who this might be right for
Lung Cancer
William Osler Health System 25,000
Not applicableEnded earlyNCT05289466
What this trial is testing

Oncoplastic Partial Mastectomy With Intraoperative Radiation Therapy (IORT) in Early Stage Breast Cancer Patients With Prior History of Chest Wall Radiation.

Who this might be right for
IORT-Intra-Operative Radiation Therapy
Saint John's Cancer Institute 5
Early research (Phase 1)Ended earlyNCT04510415
What this trial is testing

Olmutinib 600 mg QD in Patients With T790M-positive NSCLC After Treatment With an EGFR-TKI

Who this might be right for
Non Small Cell Lung Cancer
Hanmi Pharmaceutical Company Limited 2
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06752408
What this trial is testing

Aumolertinib Versus Osimertinib As First-line Therapy for Patients with EGFR Mutated Locally Advanced or Metastatic Non-small-cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Peking Union Medical College Hospital 316
Large-scale testing (Phase 3)Looking for participantsNCT06646276
What this trial is testing

Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).

Who this might be right for
Extensive-Stage Small Cell Lung Cancer
Bristol-Myers Squibb 530
Testing effectiveness (Phase 2)Study completedNCT03406468
What this trial is testing

Re-Induction After Initial Response With Immune Therapy With Radiotherapy in Lung Cancer

Who this might be right for
Non-Small Cell Carcinoma of Lung, TNM Stage 4
Maastricht Radiation Oncology 36
Testing effectiveness (Phase 2)UnknownNCT00104780
What this trial is testing

Vaccine Therapy in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Epimmune
Testing effectiveness (Phase 2)Ended earlyNCT03148327
What this trial is testing

Astra Zeneca (Immuno Stereotactic Ablative Body Radiotherapy) ISABR Study: Randomized Phase I/II Study of Stereotactic Body Radiotherapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Jonsson Comprehensive Cancer Center 18
Testing effectiveness (Phase 2)Temporarily pausedNCT07639242
What this trial is testing

Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC

Who this might be right for
Lung CancerLung Cancer (NSCLC)Locally Advanced NSCLC+1 more
UNC Lineberger Comprehensive Cancer Center 60
Not applicableStudy completedNCT03004586
What this trial is testing

Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Using a 22 vs 25-Gauge Needle

Who this might be right for
Malignant Neoplasm of Respiratory and Intrathoracic Organ CarcinomaLung Cancer
M.D. Anderson Cancer Center 61
Testing effectiveness (Phase 2)Study completedNCT00305786
What this trial is testing

Gemcitabine and Oxaliplatin as Second-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of Miami 30
Not applicableWithdrawnNCT00880386
What this trial is testing

Losartan in Treating Pulmonary Fibrosis in Patients With Stage I, II, or III Non-Small Cell Lung Cancer

Who this might be right for
DyspneaLung CancerPulmonary Complications+1 more
University of South Florida
Testing effectiveness (Phase 2)Study completedNCT00003283
What this trial is testing

Octreotide With or Without Prednisone in Treating Patients With Metastatic or Recurrent Thymoma

Who this might be right for
Thymoma and Thymic Carcinoma
Eastern Cooperative Oncology Group 38
Early research (Phase 1)Active Not RecruitingNCT07457541
What this trial is testing

Molecular Imaging of Fibroblast Activation Protein Expression Using Labeled Technetium-99m HYNIC-FAPI

Who this might be right for
Lung Cancer (Locally Advanced or Metastatic)Pancreas Cancer, MetastaticBreast Cancer (Locally Advanced or Metastatic)+1 more
Tomsk National Research Medical Center of the Russian Academy of Sciences 15
Next Page